Dako, founded in 1966 and based in Glostrup, Denmark, is a privately held firm that develops flow cytometry, pathology, and other cell-based cancer diagnostics products. The firm's pathology research reagents, kits, and instruments allow researchers and clinicians to study of diseases in cells, tissue, and organs. The company is known for its pharmDx (TM) and ACIS (R) III products. ACIS III is a pathology laboratory image analysis and workflow management system. Dako EyeShare (TM) microscopy software allows pathologists to share digital slides. The firm also develops flow cytometry reagents and instruments. The products are marketed to researchers. Dako provides hospital laboratories with antibodies that are employed in immunochemistry analyses. The antibodies allow users to measure protein concentrations in blood, urine, and cerebrospinal fluid. The Eridan (TM) system, introduced in 2006, automates cancer diagnostics processing. Dako maintains manufacturing facilities in Denmark and the United States. It has earned ISO 9001:2000, ISO 13485:2003, and other certifications. The firm has subsidiaries in 19 countries. It works with distributors in 53 countries. Dako has acquired Novo Nordisk Diagnostics and CytoLogix Incorporated's Artisan (TM) instrument business. Dako was founded as DAKOPATTS by Dr. Niels Harboe. The firm changed its name to DAKO in 1990. In 2002, it merged with Cytomation, becoming DakoCytomation. It was renamed Dako A/S in 2005. Private equity firm EQT V acquired Dako in 2007.